chrX-155507095-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2
The NM_018196.4(TMLHE):āc.798T>Cā(p.Gly266=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000902 in 1,207,808 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 36 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.000063 ( 0 hom., 2 hem., cov: 22)
Exomes š: 0.000093 ( 0 hom. 34 hem. )
Consequence
TMLHE
NM_018196.4 synonymous
NM_018196.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.625
Genes affected
TMLHE (HGNC:18308): (trimethyllysine hydroxylase, epsilon) This gene encodes the protein trimethyllysine dioxygenase which is the first enzyme in the carnitine biosynthesis pathway. Carnitine play an essential role in the transport of activated fatty acids across the inner mitochondrial membrane. The encoded protein converts trimethyllysine into hydroxytrimethyllysine. A pseudogene of this gene is found on chromosome X. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.41).
BP6
Variant X-155507095-A-G is Benign according to our data. Variant chrX-155507095-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 749213.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.625 with no splicing effect.
BS2
High AC in GnomAd4 at 7 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TMLHE | NM_018196.4 | c.798T>C | p.Gly266= | synonymous_variant | 6/8 | ENST00000334398.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TMLHE | ENST00000334398.8 | c.798T>C | p.Gly266= | synonymous_variant | 6/8 | 1 | NM_018196.4 | P1 | |
TMLHE | ENST00000369439.4 | c.798T>C | p.Gly266= | synonymous_variant | 6/7 | 1 | |||
TMLHE-AS1 | ENST00000452506.1 | n.67+17706A>G | intron_variant, non_coding_transcript_variant | 5 | |||||
TMLHE | ENST00000675642.1 | c.831T>C | p.Gly277= | synonymous_variant | 7/9 |
Frequencies
GnomAD3 genomes AF: 0.0000628 AC: 7AN: 111422Hom.: 0 Cov.: 22 AF XY: 0.0000593 AC XY: 2AN XY: 33716
GnomAD3 genomes
AF:
AC:
7
AN:
111422
Hom.:
Cov.:
22
AF XY:
AC XY:
2
AN XY:
33716
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000493 AC: 9AN: 182680Hom.: 0 AF XY: 0.0000297 AC XY: 2AN XY: 67440
GnomAD3 exomes
AF:
AC:
9
AN:
182680
Hom.:
AF XY:
AC XY:
2
AN XY:
67440
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000930 AC: 102AN: 1096386Hom.: 0 Cov.: 30 AF XY: 0.0000938 AC XY: 34AN XY: 362458
GnomAD4 exome
AF:
AC:
102
AN:
1096386
Hom.:
Cov.:
30
AF XY:
AC XY:
34
AN XY:
362458
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000628 AC: 7AN: 111422Hom.: 0 Cov.: 22 AF XY: 0.0000593 AC XY: 2AN XY: 33716
GnomAD4 genome
AF:
AC:
7
AN:
111422
Hom.:
Cov.:
22
AF XY:
AC XY:
2
AN XY:
33716
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Mar 01, 2023 | TMLHE: BP4, BP7, BS2 - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 30, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at